Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07903389Completed
Randomised trial of ciprofol and remimazolam in Colorectal disease (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Quality of Recovery-15 at 1 day. Started Feb 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07903389.